Full Approval Could Pave Way For Setting COVID-19 Vaccine Market Price

By John Wilkerson / July 30, 2021 at 1:19 PM
Full FDA approval of Pfizer’s coronavirus vaccine might pave the way for the company to set a market price, according to a source following vaccine developments, but the government already bought enough doses to provide free boosters and shots for kids under 12, should FDA approve those indications. Initially, a full approval would only apply to the two-dose vaccination, so if the government determines that a booster is needed, FDA would likely authorize its emergency use at first, and the...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.